Skip to main content
Top
Published in: Abdominal Radiology 7/2019

01-07-2019 | Computed Tomography | Hepatobiliary

Abdominal manifestations of hereditary hemorrhagic telangiectasia: a series of 333 patients over 15 years

Authors: Christopher L. Welle, Brian T. Welch, Waleed Brinjikji, Eric C. Ehman, Sudhakar K. Venkatesh, Matthew P. Johnson, Vivek N. Iyer, Michael D. Leise, Christopher P. Wood

Published in: Abdominal Radiology | Issue 7/2019

Login to get access

Abstract

Purpose

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant multi-organ vascular disorder that commonly affects the gastrointestinal tract and the liver resulting in telangiectasias and arteriovenous malformations (AVMs). Previous studies looking at the prevalence of liver and abdominal organ involvement in HHT have been limited by differing imaging techniques and sample size limitations. We sought to define the prevalence of HHT related abdominal vascular abnormalities using optimized multiphasic contrast-enhanced abdominal computed tomography (CT) exams in a large cohort of HHT patients.

Methods

Between January 2001 and May 2015; we identified a total of 333 consecutive HHT patients who had undergone a dedicated HHT protocol multiphase abdominal CT at our institution. The CT exams were reviewed by three board certified abdominal radiologists for the presence of vascular abnormalities involving the liver, pancreas, spleen, and other abdominal organs. Vascular abnormalities involving the liver were further categorized as telangiectasias, large confluent vascular masses, perfusion abnormalities, or hepatic shunts.

Results

In patients with abdominal vascular abnormalities, the liver was the most commonly involved organ, with 180 out of 333 (54.1%) patients demonstrating at least one hepatic vascular abnormality (telangiectasia, confluent vascular mass, transient perfusion abnormalities, and hepatic shunts), with most (70.0%) demonstrating multiple hepatic vascular abnormalities. The other most common organs involved included the pancreas (18.0%), spleen (6.3%), and small bowel (4.5%).

Conclusion

In patients with the clinical diagnosis of HHT, greater than half demonstrate an abdominal vascular abnormality, with the most commonly involved organ being the liver. These may be under recognized on routine or single phase contrast-enhanced CT of the abdomen. This supports the use of optimized multiphasic abdominal CT exams as an important tool for the evaluation and screening of patients with HHT.
Literature
2.
go back to reference Kjeldsen AD, Vase P, Green A (2000) [Hereditary hemorrhagic telangiectasia. A population-based study on prevalence and mortality among Danish HHT patients]. Ugeskr Laeger 162 (25):3597-3601 Kjeldsen AD, Vase P, Green A (2000) [Hereditary hemorrhagic telangiectasia. A population-based study on prevalence and mortality among Danish HHT patients]. Ugeskr Laeger 162 (25):3597-3601
4.
go back to reference Peery WH (1987) Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 82 (5):989-997CrossRefPubMed Peery WH (1987) Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 82 (5):989-997CrossRefPubMed
6.
go back to reference Siddiki H, Doherty MG, Fletcher JG, Stanson AW, Vrtiska TJ, Hough DM, Fidler JL, McCollough CH, Swanson KL (2008) Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT. Radiographics 28 (1):171-184. https://doi.org/10.1148/rg.281075037 CrossRef Siddiki H, Doherty MG, Fletcher JG, Stanson AW, Vrtiska TJ, Hough DM, Fidler JL, McCollough CH, Swanson KL (2008) Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT. Radiographics 28 (1):171-184. https://​doi.​org/​10.​1148/​rg.​281075037 CrossRef
7.
go back to reference Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91 (1):66-67CrossRefPubMed Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91 (1):66-67CrossRefPubMed
11.
go back to reference Ravard G, Soyer P, Boudiaf M, Terem C, Abitbol M, Yeh JF, Brouard R, Hamzi L, Rymer R (2004) Hepatic involvement in hereditary hemorrhagic telangiectasia: helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr 28 (4):488-495CrossRefPubMed Ravard G, Soyer P, Boudiaf M, Terem C, Abitbol M, Yeh JF, Brouard R, Hamzi L, Rymer R (2004) Hepatic involvement in hereditary hemorrhagic telangiectasia: helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr 28 (4):488-495CrossRefPubMed
14.
go back to reference Reilly PJ, Nostrant TT (1984) Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 79 (5):363-367PubMed Reilly PJ, Nostrant TT (1984) Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 79 (5):363-367PubMed
16.
18.
go back to reference Greve E, Moussata D, Gaudin JL, Lapalus MG, Giraud S, Dupuis-Girod S, Calender A, Plauchu H, Saurin JC (2010) High diagnostic and clinical impact of small-bowel capsule endoscopy in patients with hereditary hemorrhagic telangiectasia with overt digestive bleeding and/or severe anemia. Gastrointest Endosc 71 (4):760-767. https://doi.org/10.1016/j.gie.2009.11.004 CrossRefPubMed Greve E, Moussata D, Gaudin JL, Lapalus MG, Giraud S, Dupuis-Girod S, Calender A, Plauchu H, Saurin JC (2010) High diagnostic and clinical impact of small-bowel capsule endoscopy in patients with hereditary hemorrhagic telangiectasia with overt digestive bleeding and/or severe anemia. Gastrointest Endosc 71 (4):760-767. https://​doi.​org/​10.​1016/​j.​gie.​2009.​11.​004 CrossRefPubMed
21.
go back to reference Proctor DD, Henderson KJ, Dziura JD, Longacre AV, White RI, Jr. (2005) Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 39 (2):115-119PubMed Proctor DD, Henderson KJ, Dziura JD, Longacre AV, White RI, Jr. (2005) Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 39 (2):115-119PubMed
Metadata
Title
Abdominal manifestations of hereditary hemorrhagic telangiectasia: a series of 333 patients over 15 years
Authors
Christopher L. Welle
Brian T. Welch
Waleed Brinjikji
Eric C. Ehman
Sudhakar K. Venkatesh
Matthew P. Johnson
Vivek N. Iyer
Michael D. Leise
Christopher P. Wood
Publication date
01-07-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01976-7

Other articles of this Issue 7/2019

Abdominal Radiology 7/2019 Go to the issue

Classics in Abdominal Radiology

Bare area sign

Classics in Abdominal Radiology

The stalk-of-corn sign of ureter

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.